doi: 10.1016/j.ejphar.2008.06.054.
Epub 2008 Jun 19.
The mGlu(4) receptor allosteric modulator N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide acts as a direct agonist at mGlu(6) receptors
Affiliations
- PMID: 18593581
- DOI: 10.1016/j.ejphar.2008.06.054
Item in Clipboard
The mGlu(4) receptor allosteric modulator N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide acts as a direct agonist at mGlu(6) receptors
Eur J Pharmacol.
.
Abstract
Effects of the mGlu(4) receptor allosteric modulator N-phenyl-7-(hydroxyimino)cyclopropa[b]chromen-1a-carboxamide (PHCCC) were tested on closely related mGlu6 receptors. Modulation of native calcium currents in isolated sympathetic neurons from rat superior cervical ganglion by expressed mGlu(4) and mGlu(6) receptor was used to assay receptor activity. Glutamate concentration-response curves with and without PHCCC confirmed that the drug is an allosteric modulator of mGlu(4) receptor, without direct agonist activity. Conversely, PHCCC directly activates the mGlu(6) receptor and does not enhance activity of glutamate. Therefore, PHCCC is a direct mGlu(6) receptor agonist, but lacks allosteric modulatory properties.
Similar articles
-
Functional and pharmacological characteristics of metabotropic glutamate receptors 2/4 heterodimers.Mol Pharmacol. 2012 Sep;82(3):438-47. doi: 10.1124/mol.112.078501. Epub 2012 May 31. Mol Pharmacol. 2012. PMID: 22653971 Free PMC article.
-
Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats.Amino Acids. 2007 Feb;32(2):169-72. doi: 10.1007/s00726-006-0316-z. Epub 2006 Aug 2. Amino Acids. 2007. PMID: 16868652
-
Anxiolytic-like effects of PHCCC, an allosteric modulator of mGlu4 receptors, in rats.Eur J Pharmacol. 2004 Sep 13;498(1-3):153-6. doi: 10.1016/j.ejphar.2004.07.001. Eur J Pharmacol. 2004. PMID: 15363989
-
Neurobiological Insights from mGlu Receptor Allosteric Modulation.Int J Neuropsychopharmacol. 2016 Apr 29;19(5):pyv133. doi: 10.1093/ijnp/pyv133. Print 2016 May. Int J Neuropsychopharmacol. 2016. PMID: 26647381 Free PMC article. Review.
-
Recent patents on positive allosteric modulators of the metabotropic glutamate 5 receptor as a potential treatment for schizophrenia.Recent Pat CNS Drug Discov. 2010 Jan;5(1):23-34. doi: 10.2174/157488910789753512. Recent Pat CNS Drug Discov. 2010. PMID: 19832691 Review.
Cited by
-
Molecular Insights into Metabotropic Glutamate Receptor Allosteric Modulation.Mol Pharmacol. 2015 Jul;88(1):188-202. doi: 10.1124/mol.114.097220. Epub 2015 Mar 25. Mol Pharmacol. 2015. PMID: 25808929 Free PMC article.
-
Progress toward advanced understanding of metabotropic glutamate receptors: structure, signaling and therapeutic indications.Cell Signal. 2014 Oct;26(10):2284-97. doi: 10.1016/j.cellsig.2014.04.022. Epub 2014 May 2. Cell Signal. 2014. PMID: 24793301 Free PMC article. Review.
-
Functional and pharmacological characteristics of metabotropic glutamate receptors 2/4 heterodimers.Mol Pharmacol. 2012 Sep;82(3):438-47. doi: 10.1124/mol.112.078501. Epub 2012 May 31. Mol Pharmacol. 2012. PMID: 22653971 Free PMC article.
-
Allosteric modulation of metabotropic glutamate receptors.Adv Pharmacol. 2011;62:37-77. doi: 10.1016/B978-0-12-385952-5.00010-5. Adv Pharmacol. 2011. PMID: 21907906 Free PMC article. Review.
-
mGluR4-positive allosteric modulation as potential treatment for Parkinson's disease.Future Med Chem. 2009 Jun;1(3):501-13. doi: 10.4155/fmc.09.38. Future Med Chem. 2009. PMID: 20161443 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
